We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+19.73%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$48.2B
AUM Growth
+$6.85B
(+17%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
16.16%
Holding
1,043
New
80
Increased
251
Reduced
497
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$281M |
| 2 |
NRG Energy
NRG
|
+$136M |
| 3 |
Public Service Enterprise Group
PEG
|
+$123M |
| 4 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$122M |
| 5 |
State Street
STT
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$254M |
| 2 |
Eaton
ETN
|
+$221M |
| 3 |
RTN
Raytheon Company
RTN
|
+$219M |
| 4 |
JPMorgan Chase
JPM
|
+$185M |
| 5 |
AbbVie
ABBV
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.83% |
| 2 | Healthcare | 16.38% |
| 3 | Technology | 14.36% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
| $393M | 0.81% |
3,499,434
+2,650,007
| +312% | +$281M |
|
27
IBM
IBM
$222B
| $380M | 0.79% |
3,294,192
+34,336
| +1% | +$3.99M |
|
|
28
AbbVie
ABBV
$451B
| $370M | 0.77% |
3,771,973
-1,773,550
| -32% | -$156M |
|
29
Valero Energy
VLO
$101B
| $357M | 0.74% |
6,072,252
-282,752
| -4% | -$16.9M |
|
30
HCA Healthcare
HCA
$90.5B
| $350M | 0.73% |
3,603,216
-345,970
| -9% | -$36M |
|
31
Gilead Sciences
GILD
$181B
| $347M | 0.72% |
4,512,168
+16,944
| +0.4% | +$1.3M |
|
32
Tyson Foods
TSN
$19.5B
| $345M | 0.71% |
5,771,260
-140,996
| -2% | -$8.55M |
|
33
Phillips 66
PSX
$97.4B
| $342M | 0.71% |
4,753,501
+133,081
| +3% | +$9.42M |
|
34
Amdocs
DOX
$6.57B
| $312M | 0.65% |
5,125,823
+1,587,293
| +45% | +$98M |
|
35
Eastman Chemical
EMN
$8.35B
| $310M | 0.64% |
4,457,307
-193,879
| -4% | -$12.2M |
|
36
Morgan Stanley
MS
$337B
| $297M | 0.61% |
6,139,491
-278,653
| -4% | -$11.7M |
|
37
Whirlpool
WHR
$2.68B
| $294M | 0.61% |
2,267,101
+24,615
| +1% | +$2.82M |
|
38
Lam Research
LRCX
$378B
| $279M | 0.58% |
8,615,720
-5,056,380
| -37% | -$138M |
|
|
39
State Street
STT
$53.1B
| $274M | 0.57% |
4,313,370
+1,919,301
| +80% | +$116M |
|
40
Ingredion
INGR
$6.6B
| $273M | 0.57% |
3,292,807
+71,258
| +2% | +$5.83M |
|
41
Seagate
STX
$188B
| $272M | 0.56% |
5,616,981
+218,082
| +4% | +$10.9M |
|
42
Huntington Ingalls Industries
HII
$11.6B
| $271M | 0.56% |
1,555,501
+106,613
| +7% | +$19.8M |
|
43
Biogen
BIIB
$32.3B
| $270M | 0.56% |
1,007,758
-67,119
| -6% | -$20.2M |
|
44
Regions Financial
RF
$25.8B
| $257M | 0.53% |
23,114,125
-1,144,586
| -5% | -$12.2M |
|
45
HP
HPQ
$27.5B
| $256M | 0.53% |
14,683,415
+397,169
| +3% | +$6.31M |
|
46
Pultegroup
PHM
$24.5B
| $256M | 0.53% |
7,517,691
-311,424
| -4% | -$9.35M |
|
47
Best Buy
BBY
$17.4B
| $255M | 0.53% |
2,926,488
-55,606
| -2% | -$4.22M |
|
48
McKesson
MCK
$104B
| $249M | 0.52% |
1,623,403
+11,666
| +0.7% | +$1.68M |
|
|
DFS
49
DELISTED
Discover Financial Services
DFS
| $248M | 0.51% |
4,951,014
-260,010
| -5% | -$11.4M |
|
50
Jazz Pharmaceuticals
JAZZ
$15.9B
| $246M | 0.51% |
2,225,431
+363,015
| +19% | +$40.1M |
|
Similar funds
HF
LSV Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, LSV Asset Management held 1,043 positions worth $48.2B, up 17% from $41.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LSV Asset Management's Q2 2020 filing shows 80 new, 251 increased, 497 reduced and 58 closed positions. Its largest new stake was Fox Class A: 3,234,370 shares worth $86.7M. The largest sale was Caterpillar, an estimated $254M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- LSV Asset Management's largest Q2 2020 buy was Fox Class A: 3,234,370 shares worth $86.7M.
- LSV Asset Management added most to Alexion Pharmaceuticals in Q2 2020, an estimated $281M increase.
- LSV Asset Management's biggest Q2 2020 reduction was Caterpillar, cutting an estimated $254M.
- LSV Asset Management fully exited Raytheon Company in Q2 2020, selling an estimated $219M.
- LSV Asset Management's ten largest holdings make up 16% of its $48.2B portfolio in Q2 2020.
- LSV Asset Management opened 80 new positions and closed 58 in Q2 2020.
- LSV Asset Management's portfolio value rose 17% quarter-over-quarter to $48.2B.
Based on LSV Asset Management's 13F filing for Q2 2020, filed 5 Aug 2020.